S7.005. Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke Reulsts from ACTION, a Multicenter, Double-blind, Plac 医学讲坛 2022年06月01日 5 点赞 0 评论 600 浏览
rtPA Administration for Acute Ischemic Stroke - 20 year perspective 医学讲坛 2022年06月01日 22 点赞 0 评论 302 浏览
Retinal and visual cortex damage and higher order visual dysfunction in carriers of E46K mutation of alpha-synuclein gene 医学讲坛 2022年06月01日 22 点赞 0 评论 724 浏览
Results from a Multicenter Phase II Randomized Tiral of a Prolyl Hydroxylase Inhibitor for Neuroprotection in High Risk Thoracic 医学讲坛 2022年06月01日 54 点赞 0 评论 225 浏览
Resolved Serum JCV Antibody Status should be Assessed Prior to Initiating Natalizumab or New MS Therapies and JCV-positive MS Pa 医学讲坛 2022年06月01日 47 点赞 0 评论 214 浏览
Resolved MS Disease Modifying Medications can be Discontinued in Patients with Stable Disease 医学讲坛 2022年06月01日 26 点赞 0 评论 144 浏览
